480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions — STANCE

Atherosclerosis of Femoral Artery Clinical Trial

Official title:
A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions

Status Completed

Clinical Trial Summary

This is an initial evaluation of the 480 Biomedical Bioresorbable Scaffold System for the treatment of subjects with de novo native superficial femoral artery lesions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Atherosclerosis
Atherosclerosis of Femoral Artery
Superficial Femoral Artery Lesions

Clinical Trial Details

NCT number	NCT01403077
Study type	Interventional
Source	Lyra Therapeutics
Contact
Status	Completed
Phase	N/A
Start date	October 2011
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03271710` - Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System	N/A
Completed	`NCT01327950` - Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions	N/A
Completed	`NCT01700075` - Physical and Chemical Study of Atherosclerosis Mechanisms	Phase 4
Active, not recruiting	`NCT04597307` - IN.PACT™ Quality of Life Post-Reimbursement Study
Recruiting	`NCT03751527` - ZENFlex-Registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty	N/A